Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting

American Heart Journal

Volumn 150, Issue 3, 2005, Pages 550-556

  Braun, Siegmund ^a   Ndrepepa, Gjin ^a   Von Beckerath, Nicolas ^a   Mehilli, Julinda ^a   Gorchakova, Olga ^a   Vogt, Wolfgang ^a   Schömig, Albert ^a,b   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATION-REDUCTION; STENTS; TREATMENT OUTCOME;

EID: 24944494049     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.10.008     Document Type: Article

References (38)

1. D. Steinberg, and A. Lewis Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis Circulation 95 1997 1062 1071
2. J. Regnstrom, J. Nilsson, and P. Tornvall Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man Lancet 339 1992 1183 1186
3. S. Toshima, A. Hasegawa, and M. Kurabayashi Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease Arterioscler Thromb Vasc Biol 20 2000 2243 2247
4. J.T. Salonen, S. Yla-Herttuala, and R. Yamamoto Autoantibody against oxidised LDL and progression of carotid atherosclerosis Lancet 339 1992 883 887
5. T. Vasankari, M. Ahotupa, and J. Toikka Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy Atherosclerosis 155 2001 403 412
6. E. Maggi, R. Chiesa, and G. Melissano LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers Arterioscler Thromb Vasc Biol 14 1994 1892 1899
7. C. Bergmark, R. Wu, and U. de Faire Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL Arterioscler Thromb Vasc Biol 15 1995 441 445
8. O.T. Raitakari, O.P. Pitkanen, and T. Lehtimaki In vivo low density lipoprotein oxidation relates to coronary reactivity in young men J Am Coll Cardiol 30 1997 97 102
9. W.F. Penny, O. Ben-Yehuda, and K. Kuroe Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein J Am Coll Cardiol 37 2001 766 774
10. S. Ehara, M. Ueda, and T. Naruko Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes Circulation 103 2001 1955 1960
11. K. Nishi, H. Itabe, and M. Uno Oxidized LDL in carotid plaques and plasma associates with plaque instability Arterioscler Thromb Vasc Biol 22 2002 1649 1654
12. H. Itabe Oxidized low-density lipoproteins: what is understood and what remains to be clarified Biol Pharm Bull 26 2003 1 9
13. J.A. Berliner, M. Navab, and A.M. Fogelman Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics Circulation 91 1995 2488 2496
14. S. Tsimikas, C. Bergmark, and R.W. Beyer Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes J Am Coll Cardiol 41 2003 360 370
15. P. Holvoet, J. Vanhaecke, and S. Janssens Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease Circulation 98 1998 1487 1494
16. P. Holvoet, D. Collen, and F. Van de Werf Malondialdehyde-modified LDL as a marker of acute coronary syndromes JAMA 281 1999 1718 1721
17. G. Nordin Fredrikson, B. Hedblad, and G. Berglund Plasma oxidized LDL: a predictor for acute myocardial infarction? J Intern Med 253 2003 425 429
18. B. Eber, M. Schumacher, and F. Tatzber Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty Cardiology 84 1994 310 315
19. J. George, D. Harats, and E. Bakshi Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty Immunol Lett 68 1999 263 266
20. A. Boullier, E. Walters-Laporte, and M. Hamon Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty Clin Chim Acta 299 2000 129 140
21. World Health Organization Diabetes mellitus World Health Organ Tech Rep Ser 727 1985 1 104
22. P. Holvoet, J. Donck, and M. Landeloos Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure Thromb Haemost 76 1996 663 669
23. S.G. Ellis, M.G. Vandormael, and M.J. Cowley Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group Circulation 82 1990 1193 1202
24. G.E. Austin, J. Hollman, and M.J. Lynn Serum lipoprotein levels fail to predict postangioplasty recurrent coronary artery stenosis Cleve Clin J Med 56 1989 509 514
25. G.J. Reis, R.E. Kuntz, and D.I. Silverman Effects of serum lipid levels on restenosis after coronary angioplasty Am J Cardiol 68 1991 1431 1435
26. P.K. Shah, and J. Amin Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty Circulation 85 1992 1279 1285
27. Y. Rozenman, D. Gilon, and S. Welber Plasma lipoproteins are not related to restenosis after successful coronary angioplasty Am J Cardiol 72 1993 1206 1207
28. R. Hoffmann, G.S. Mintz, and G.R. Dussaillant Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study Circulation 94 1996 1247 1254
29. P.R. Moreno, J.T. Fallon, and A.M. Murcia Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients J Am Coll Cardiol 34 1999 1045 1049
30. W.S. Weintraub, A.S. Kosinski, and C.L. Brown III Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 21 1993 6 14
31. C. Landau, R.A. Lange, and L.D. Hillis Percutaneous transluminal coronary angioplasty N Engl J Med 330 1994 981 993
32. B. Bjorkerud, and S. Bjorkerud Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts Arterioscler Thromb Vasc Biol 16 1996 416 424
33. C. Napoli, O. Quehenberger, and F. De Nigris Mildly oxidized low density lipoprotein activates multiple apoptotic signalling pathways in human coronary cells FASEB J 14 2000 1996 2007
34. L.M. Giroux, J. Davignon, and M. Naruszewicz Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages Biochim Biophys Acta 1165 1993 335 338
35. A. Schömig, J. Mehilli, and H. Holle Statin treatment following coronary artery stenting and one-year survival J Am Coll Cardiol 40 2002 854 861
36. P.M. Ridker, N. Rifai, and M.A. Pfeffer Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators Circulation 98 1998 839 844
37. U. Laufs, V. La Fata, and J. Plutzky Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
38. A. Undas, K.E. Brummel, and J. Musial Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation Circulation 103 2001 2248 2253